NDC 0603-3079 is a in the category. It is labeled and distributed by .
Proprietary Name | NDC 0603-3079 |
Marketing Category | / |
Marketing Category | ANDA |
Application Number | ANDA077797 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-02-28 |
Marketing End Date | 2018-10-31 |
Marketing Category | ANDA |
Application Number | ANDA077797 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-02-28 |
Marketing End Date | 2018-10-31 |
Marketing Category | ANDA |
Application Number | ANDA077797 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-02-28 |
Marketing End Date | 2018-10-31 |
Marketing Category | ANDA |
Application Number | ANDA077797 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-02-28 |
Marketing End Date | 2018-10-31 |
Marketing Category | ANDA |
Application Number | ANDA077797 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2007-02-28 |
Marketing End Date | 2018-10-31 |
Marketing Category | ANDA |
Application Number | ANDA077797 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-02-28 |
Marketing End Date | 2018-10-31 |
Marketing Category | ANDA |
Application Number | ANDA077797 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-02-28 |
Marketing End Date | 2018-10-31 |
Marketing Category | ANDA |
Application Number | ANDA077797 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2007-02-28 |
Marketing End Date | 2018-10-31 |